ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

Anne Brecht Francken, Josette E H M Hoekstra-Weebers, Eric Deckers, Harald J Hoekstra*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

83 Downloads (Pure)
Original languageEnglish
Pages (from-to)1418-1419
Number of pages2
JournalAnnals of Surgical Oncology
Issue number5
Early online date3-Sept-2019
Publication statusPublished - 1-May-2020

Cite this